Dentsply Sirona Inc. revenue
Dentsply Sirona Inc.'s revenue was $3.68bn in fiscal 2025, down 3.0% on the year before. Since fiscal 2009 ($2.16bn) it has grown at a compound 3.4% a year. Over the last twelve months it was $3.64bn.
Revenue history
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,159 | 2,221 | 2,538 | 2,928 | 2,951 | 2,923 | 2,674 | 3,745 | 3,993 | 3,986 | 4,022 | 3,339 | 4,231 | 3,922 | 3,965 | 3,793 | 3,680 | 3,643 |
| Growth on the year before | — | +2.9% | +14.3% | +15.4% | +0.8% | −1.0% | −8.5% | +40.0% | +6.6% | −0.2% | +0.9% | −17.0% | +26.7% | −7.3% | +1.1% | −4.3% | −3.0% | — |
| Gross profit | 1,106 | 1,130 | 1,273 | 1,556 | 1,577 | 1,600 | 1,517 | 2,001 | 2,189 | 2,068 | 2,164 | 1,656 | 2,347 | 2,127 | 2,086 | 1,958 | 1,840 | 1,804 |
| Gross margin | 51.2% | 50.9% | 50.2% | 53.1% | 53.5% | 54.7% | 56.7% | 53.4% | 54.8% | 51.9% | 53.8% | 49.6% | 55.5% | 54.2% | 52.6% | 51.6% | 50.0% | 49.5% |
Where the revenue comes from
| Region | Revenue | YoY |
|---|---|---|
| Other Foreign | $2.1B | ▲ 2.0% |
| Europe | $1.6B | ▲ 3.8% |
| United States | $1.2B | ▼ 12.3% |
| Rest of The World | $922M | ▼ 0.5% |
| Germany | $422M | ▲ 2.9% |
These categories overlap or exclude eliminations, so shares aren't shown.
From Dentsply Sirona Inc.'s 10-K filed February 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Dentsply Sirona Inc. | $3.64bn | -0.8% | -2.5% |
| West Pharmaceutical Services | $3.40bn | 12.6% | 5.1% |
| Align Technology | $4.14bn | 4.4% | 3.5% |
| The Cooper Companies | $4.24bn | 4.7% | 6.4% |
| Envista Holdings Corp | $2.86bn | 11.9% | 3.4% |
| ICU Medical Inc | $2.16bn | -9.0% | -2.0% |
Compare with peers
- West Pharmaceutical Services revenue
- Align Technology revenue
- The Cooper Companies revenue
- Envista Holdings Corp revenue
- ICU Medical Inc revenue
Head to head: WST vs XRAYALGN vs XRAYCOO vs XRAYNVST vs XRAY
More: Health Care Supplies stocks compared, Health Care sector, rankings of US companies